Literature DB >> 11604582

Pretransfusion compatibility testing for red blood cell administration.

I A Shulman1, K A Downes, K Sazama, L M Maffei.   

Abstract

The purpose of pretransfusion compatibility testing is to prevent incompatible red blood cell transfusions that could lead to immune mediated hemolytic transfusion reactions. Some hemolytic transfusion reactions may have serious sequelae including hemoglobinemia, disseminated intravascular coagulation, renal failure, and death. This article reviews the most comprehensive recent analyses of the laboratory methods used during pretransfusion compatibility testing in the United States. Most of the laboratory practice data have been published in the College of American Pathologists Transfusion Medicine Survey Sets and in a national survey called the Pre-Transfusion Testing Survey. This article couples and trends the data of these comprehensive surveys with an assessment of the literature to present the current practice of pretransfusion compatibility testing.

Entities:  

Mesh:

Year:  2001        PMID: 11604582     DOI: 10.1097/00062752-200111000-00014

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  5 in total

1.  Evaluation of Four Bedside Test Systems for Card Performance, Handling and Safety.

Authors:  Felix Giebel; Susanne M Picker; Birgit S Gathof
Journal:  Transfus Med Hemother       Date:  2007-12-03       Impact factor: 3.747

2.  Can the interval between antibody identifications be increased for alloimmunized patients?

Authors:  Cheryl Goss; Scott T Avecilla; Jennifer Garbaini; Diana Degtyaryova; Dian Lo; Dustin Y M Chang; Melissa Cushing
Journal:  Transfusion       Date:  2015-10-12       Impact factor: 3.157

3.  Comparison of micro column technology with conventional tube methods for antibody detection.

Authors:  Sachin Garg; Nishant Saini; Ravneet Kaur Bedi; Sabita Basu
Journal:  J Lab Physicians       Date:  2017 Apr-Jun

4.  Safety of Uncrossmatched ABO-Compatible RBCs in Alloimmunized Patients with Bleeding: Data from Two Decades: Results of a Systematic Analysis in 6,109 Patients.

Authors:  Frauke Ringel; Helge Schoenfeld; Said El Bali; Jalid Sehouli; Claudia Spies; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2021-12-08       Impact factor: 4.040

5.  Immunodeficient mice are better for modeling the transfusion of human blood components than wild-type mice.

Authors:  Sophia A Blessinger; Johnson Q Tran; Rachael P Jackman; Renata Gilfanova; Jacqueline Rittenhouse; Alan G Gutierrez; John W Heitman; Kelsey Hazegh; Tamir Kanias; Marcus O Muench
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.